FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2214492077> ?p ?o ?g. }

• W2214492077 abstract "Triple negative breast cancer (TNBC) (ER-, PR-, Her2-), constituting 10-20% of all breast cancers, is a heterogeneous disease with limited treatment options and poor prognosis. TNBCs exhibit rapid progression with the duration of response to first line palliative chemotherapy typically less than 12 weeks, and overall five year survival of patients with metastatic TNBC of 22%. The cancer stem cell (CSC) model provides an attractive explanation for relapse of TNBC after primary therapy since these cells demonstrate resistance to conventional chemotherapy. CSCs which survive primary treatments, such as docetaxel, may self-renew and differentiate into the heterogeneous tumor bulk resulting in local recurrence and distant metastasis. Docetaxel has been demonstrated to not only fail to eliminate CSCs but expands this population in preclinical models. Further, docetaxel increases circulating IL-6 in patients following therapy, a cytokine reported to expand breast CSCs. Therefore, we sought to combine docetaxel with a small molecule CSC inhibitor capable of reducing IL-6 production (sulforaphane, SF) for the effective treatment of TNBCs. Our results in vitro demonstrate that docetaxel treatment (5 nM) increases the proportion of CSCs in TNBC cell lines (SUM149 and SUM159) as evident by flow cytometry analysis using the ALDEFLUOR assay (70.6±22.0%) and cells which are CD44+/CD24-/EpCAM+ (2.9 fold). Mammosphere formation assay reveals 1 nM docetaxel increases secondary sphere formation rate by 75.8±29%. As determined by ELISA, 5 nM docetaxel treatment for 72 hours induces 3.5 fold increase in IL-6 production. Conversely, SF (2.5 μM) selectively reduces the proportion of ALDEFLUOR positive cells (51.5±15.0%) and mammosphere formation (39.2±3.8%) while reducing IL-6 (55.6±5.0%) through regulation of NF-kB activity. In combination docetaxel and SF synergize to effectively reduce bulk cell line proliferation (combination index range 1-0.093). Further, SF prevents docetaxel mediated CSC expansion and IL-6 production. Using a mouse xenograft model docetaxel (10 mg/kg weekly) reduces tumor growth of established tumors by 83.2±6.0% whereas SF (50 mg/kg daily) inhibits primary tumor growth by 37.4±14.6%. In addition, secondary reimplantation assays with limiting dilution analysis reveals docetaxel increases the frequency of the tumor initiating CSCs (1/1514 control cells vs 1/330 docetaxel treated cells) while SF reduces the frequency to 1/3181 cells. In vivo, the combination of docetaxel and SF exhibits a greater reduction in primary tumor volume (92.5±2.1% reduction relative to control), and synergistically inhibit the CSC population (1 in 4245 cells). These results suggest that SF mediated inhibition of breast CSCs and IL-6 provide a scientific rationale for using this agent in combination with docetaxel for TNBC. Citation Format: Joseph P. Burnett, Ronack B. Shah, Hayley J. Paholak, Sean P. McDermott, Yasuhiro Tsume, Max W. Wicha, Duxin Sun. Combination of docetaxel with sulforaphane synergistically inhibits triple negative breast cancer and cancer stem cells. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4076. doi:10.1158/1538-7445.AM2015-4076" @default.
• W2214492077 created "2016-06-24" @default.
• W2214492077 creator A5036898947 @default.
• W2214492077 creator A5039694201 @default.
• W2214492077 creator A5056987351 @default.
• W2214492077 creator A5059193097 @default.
• W2214492077 creator A5059657103 @default.
• W2214492077 creator A5069778809 @default.
• W2214492077 creator A5087527525 @default.
• W2214492077 date "2015-08-01" @default.
• W2214492077 modified "2023-09-26" @default.
• W2214492077 title "Abstract 4076: Combination of docetaxel with sulforaphane synergistically inhibits triple negative breast cancer and cancer stem cells" @default.
• W2214492077 doi "https://doi.org/10.1158/1538-7445.am2015-4076" @default.
• W2214492077 hasPublicationYear "2015" @default.
• W2214492077 type Work @default.
• W2214492077 sameAs 2214492077 @default.
• W2214492077 citedByCount "0" @default.
• W2214492077 crossrefType "proceedings-article" @default.
• W2214492077 hasAuthorship W2214492077A5036898947 @default.
• W2214492077 hasAuthorship W2214492077A5039694201 @default.
• W2214492077 hasAuthorship W2214492077A5056987351 @default.
• W2214492077 hasAuthorship W2214492077A5059193097 @default.
• W2214492077 hasAuthorship W2214492077A5059657103 @default.
• W2214492077 hasAuthorship W2214492077A5069778809 @default.
• W2214492077 hasAuthorship W2214492077A5087527525 @default.
• W2214492077 hasConcept C121608353 @default.
• W2214492077 hasConcept C126322002 @default.
• W2214492077 hasConcept C143998085 @default.
• W2214492077 hasConcept C1491633281 @default.
• W2214492077 hasConcept C185592680 @default.
• W2214492077 hasConcept C2776694085 @default.
• W2214492077 hasConcept C2779013556 @default.
• W2214492077 hasConcept C2780110267 @default.
• W2214492077 hasConcept C2780932548 @default.
• W2214492077 hasConcept C2781190966 @default.
• W2214492077 hasConcept C28328180 @default.
• W2214492077 hasConcept C2908647359 @default.
• W2214492077 hasConcept C502942594 @default.
• W2214492077 hasConcept C530470458 @default.
• W2214492077 hasConcept C54355233 @default.
• W2214492077 hasConcept C55427017 @default.
• W2214492077 hasConcept C55493867 @default.
• W2214492077 hasConcept C71924100 @default.
• W2214492077 hasConcept C86803240 @default.
• W2214492077 hasConcept C99454951 @default.
• W2214492077 hasConceptScore W2214492077C121608353 @default.
• W2214492077 hasConceptScore W2214492077C126322002 @default.
• W2214492077 hasConceptScore W2214492077C143998085 @default.
• W2214492077 hasConceptScore W2214492077C1491633281 @default.
• W2214492077 hasConceptScore W2214492077C185592680 @default.
• W2214492077 hasConceptScore W2214492077C2776694085 @default.
• W2214492077 hasConceptScore W2214492077C2779013556 @default.
• W2214492077 hasConceptScore W2214492077C2780110267 @default.
• W2214492077 hasConceptScore W2214492077C2780932548 @default.
• W2214492077 hasConceptScore W2214492077C2781190966 @default.
• W2214492077 hasConceptScore W2214492077C28328180 @default.
• W2214492077 hasConceptScore W2214492077C2908647359 @default.
• W2214492077 hasConceptScore W2214492077C502942594 @default.
• W2214492077 hasConceptScore W2214492077C530470458 @default.
• W2214492077 hasConceptScore W2214492077C54355233 @default.
• W2214492077 hasConceptScore W2214492077C55427017 @default.
• W2214492077 hasConceptScore W2214492077C55493867 @default.
• W2214492077 hasConceptScore W2214492077C71924100 @default.
• W2214492077 hasConceptScore W2214492077C86803240 @default.
• W2214492077 hasConceptScore W2214492077C99454951 @default.
• W2214492077 hasLocation W22144920771 @default.
• W2214492077 hasOpenAccess W2214492077 @default.
• W2214492077 hasPrimaryLocation W22144920771 @default.
• W2214492077 hasRelatedWork W1177426993 @default.
• W2214492077 hasRelatedWork W1596890137 @default.
• W2214492077 hasRelatedWork W1599620353 @default.
• W2214492077 hasRelatedWork W1769069832 @default.
• W2214492077 hasRelatedWork W1977027340 @default.
• W2214492077 hasRelatedWork W2012306280 @default.
• W2214492077 hasRelatedWork W2065813130 @default.
• W2214492077 hasRelatedWork W2071015820 @default.
• W2214492077 hasRelatedWork W2312983781 @default.
• W2214492077 hasRelatedWork W2402853356 @default.
• W2214492077 hasRelatedWork W2564568243 @default.
• W2214492077 hasRelatedWork W2567622012 @default.
• W2214492077 hasRelatedWork W2740198518 @default.
• W2214492077 hasRelatedWork W2760985866 @default.
• W2214492077 hasRelatedWork W2885887177 @default.
• W2214492077 hasRelatedWork W2887509926 @default.
• W2214492077 hasRelatedWork W2887734322 @default.
• W2214492077 hasRelatedWork W2944780155 @default.
• W2214492077 hasRelatedWork W2999877594 @default.
• W2214492077 hasRelatedWork W3015187016 @default.
• W2214492077 isParatext "false" @default.
• W2214492077 isRetracted "false" @default.
• W2214492077 magId "2214492077" @default.
• W2214492077 workType "article" @default.